Osteoporosis Treatment: When to Discontinue and When to Re-start | Bone Research
Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo‐Controlled FREEDOM Trial and Its Extension - Cummings - 2018 - Journal of Bone and Mineral Research - Wiley Online Library
How Long Can You Take Prolia Injections and Prolia Side Effects
Long-term follow up after denosumab treatment for osteoporosis – rebound associated with hypercalcemia, parathyroid hyperplasia, severe bone mineral density loss, and multiple fractures: a case report | Journal of Medical Case Reports
Incidence of vertebral and non-vertebral fractures in % (and number of... | Download Scientific Diagram
Fractures After Denosumab Discontinuation: A Retrospective Study of 797 Cases - Burckhardt - 2021 - Journal of Bone and Mineral Research - Wiley Online Library
Denosumab compliance is suboptimal - Medical Independent
SAT0464 MULTIPLE REBOUND-ASSOCIATED VERTEBRAL FRACTURES AFTER DENOSUMAB DISCONTINUATION IN RHEUMATOLOGY CLINIC | Annals of the Rheumatic Diseases
Romosozumab was not effective in preventing multiple spontaneous clinical vertebral fractures after denosumab discontinuation: A case report - ScienceDirect
Vertebral fractures after denosumab cessation | Cleveland Clinic Journal of Medicine
Frontiers | A Multi-Institutional Randomized Controlled Trial to Investigate Whether Zoledronate Prevents Bone Loss After Discontinuation of Denosumab: The Study Protocol of Denosumab Sequential Therapy (DST) Trial
Frontiers | Elevated Bone Hardness Under Denosumab Treatment, With Persisting Lower Osteocyte Viability During Discontinuation
Multiple vertebral fractures following discontinuation of denosumab treatment: ten clinical cases report | Reumatología Clínica
Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative Review | SpringerLink
Prolia/Denosumab - Multiple vertebral fractures after stopping the drug | Facebook
Rebound-associated vertebral fractures after denosumab discontinuation in a lung cancer patient with bone metastases - ScienceDirect
JCM | Free Full-Text | Denosumab Discontinuation and the Rebound Phenomenon: A Narrative Review
Vertebral fractures after denosumab cessation | Cleveland Clinic Journal of Medicine
Rebound-associated vertebral fractures may occur in sequential time points following denosumab discontinuation: need for prompt treatment re-initiation - ScienceDirect
Factors Associated With the Number of Vertebral Fractures (NVFs) in the... | Download Scientific Diagram
Rebound-associated vertebral fractures after denosumab discontinuation in a lung cancer patient with bone metastases - ScienceDirect
Romosozumab was not effective in preventing multiple spontaneous clinical vertebral fractures after denosumab discontinuation: A case report - ScienceDirect
Bone Density & Osteoporosis: An Update for Manitoba Physicians: No. 14 October 1, 2019
Fractures After Denosumab Discontinuation: A Retrospective Study of 797 Cases - Burckhardt - 2021 - Journal of Bone and Mineral Research - Wiley Online Library
Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS - ScienceDirect
Rapid Bone Loss and Multiple Vertebral Fractures After Denosumab Cessation – Consult QD
